PAVmed Inc. (PAVM) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 162 transactions totaling $1.8M, demonstrating a bearish sentiment with -$831.4K in net insider flow. The most recent transaction on Sep 30, 2025 involved a transaction of 150,000 shares valued at $0.
No significant insider buying has been recorded for PAVM in the recent period.
No significant insider selling has been recorded for PAVM in the recent period.
Based on recent SEC filings, insider sentiment for PAVM is bearish with an Insider Alignment Score of 26/100 and a net flow of -$831.4K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at PAVmed Inc. (PAVM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading PAVM stock, having executed 162 transactions in the past 90 days. The most active insider is Matthew Sirovich (Executive), who has made 9 transactions totaling $756.3K.
Get notified when executives and directors at PAVM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | O'neil Shaun | Executive | Award | 150,000 | $N/A | $0 | |
| Sep 30, 2025 | Aklog Lishan | Executive | Award | 150,000 | $N/A | $0 | |
| Sep 30, 2025 | M. Mcgrath Dennis | Executive | Award | 150,000 | $N/A | $0 | |
| Sep 30, 2025 | Adam Gordon Michael | Executive | Award | 150,000 | $N/A | $0 | |
| Sep 30, 2025 | Agrawal Sundeep | Executive | Award | 150,000 | $N/A | $0 | |
| Sep 30, 2025 | J. Glennon Michael | Executive | Award | 150,000 | $N/A | $0 | |
| Sep 30, 2025 | E. Baxter Timothy | Executive | Award | 150,000 | $N/A | $0 | |
| Sep 30, 2025 | White Debra | Executive | Award | 150,000 | $N/A | $0 | |
| Sep 30, 2025 | M. Sparks Ronald | Executive | Award | 150,000 | $N/A | $0 | |
| Feb 22, 2024 | L. Cox James | Executive | Award | 65,000 | $N/A | $0 | |
| Feb 22, 2024 | J. Glennon Michael | Executive | Award | 65,000 | $N/A | $0 | |
| Feb 22, 2024 | B. Harvey Joan | Executive | Award | 65,000 | $N/A | $0 | |
| Feb 22, 2024 | M. Sparks Ronald | Executive | Award | 65,000 | $N/A | $0 | |
| Feb 22, 2024 | White Debra | Executive | Award | 65,000 | $N/A | $0 | |
| Feb 22, 2024 | E. Baxter Timothy | Executive | Award | 65,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 8 | $1.3M | 55.9% |
Payment(F) | 4 | $548.0K | 23.7% |
Purchase(P) | 95 | $460.3K | 19.9% |
Small Acquisition(L) | 4 | $10.6K | 0.5% |
Award(A) | 28 | $0 | 0.0% |
Exercise (Options)(X) | 4 | $0 | 0.0% |
Other(J) | 14 | $0 | 0.0% |
Gift(G) | 5 | $0 | 0.0% |
Insider selling pressure at PAVmed Inc. has increased, with 18 insiders executing 162 transactions across all time. Total sales of $1.3M significantly outpace purchases of $460.3K, resulting in a net outflow of $831.4K. This selling activity appears largely discretionary, which may warrant closer attention from investors.